戻る Agenda
RA Leadership Forum: Critical Deliverables in Global Regulatory Teams
Session Chair(s)
João Duarte, MPHARM, MSC
Vice President, Head of Global Regulatory Affairs Excellence
Ipsen, France
Martine Zimmermann, PHARMD
Senior Vice President, Head of Global Regulatory Affairs
Ipsen , France
A panel of RA industry leaders will discuss topics such as the management challenges of global submissions, partnering in clinical development in R&D, regulatory talent development and what’s next for regulatory science. This first DIA RA Leadership Forum intends to offer a platform for debate, discussion and reflection on the role of regulatory professionals in modern R&D. Europe remains an area where a pool of RA Leaders work every day in global strategies, using innovation to facilitate and expedite drug development decision making.
Learning Objective : Participants will hear from senior RA leaders on current expectations for (global) regulatory strategies and deliverables in R&D; Participants will be able to gather advice from senior RA leaders on current challenges and opportunities for regulatory teams, from submission strategies to career development trends; RA professionals will leave more informed about their role in modern R&D.
Speaker(s)
Panelist
Gerhard Schlueter, DRSC, MSC
Bayer AG, Germany
Head of Strategic and Technical Operations, Regulatory Affairs
Panelist
Karin Van Baelen, PHARMD
Janssen, Belgium
Head, Global Regulatory Affairs
Panelist
Marc Martinell
Mynorix, Spain
CEO
Panelist
Clothilde Barlet
Biomarin, United Kingdom
Manager Regulatory Affairs
Panelist
Detlef Hold, MSC
F. Hoffmann La Roche, Switzerland
Global Strategy Lead Knowledge Cycling & Learning